These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22804770)

  • 21. Serum levels of advanced glycation end products (AGEs) are inversely associated with the number and migratory activity of circulating endothelial progenitor cells in apparently healthy subjects.
    Ueda S; Yamagishi S; Matsui T; Noda Y; Ueda S; Jinnouchi Y; Sasaki K; Takeuchi M; Imaizumi T
    Cardiovasc Ther; 2012 Aug; 30(4):249-54. PubMed ID: 21884000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased levels of serum matrix metalloproteinase-3 in haemodialysis patients with dialysis-related amyloidosis.
    Naganuma T; Sugimura K; Uchida J; Tashiro K; Yoshimura R; Takemoto Y; Nakatani T
    Nephrology (Carlton); 2008 Apr; 13(2):104-8. PubMed ID: 18275497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reference values of skin autofluorescence as an estimation of tissue accumulation of advanced glycation end products in a general Slovak population.
    Simon Klenovics K; Kollárová R; Hodosy J; Celec P; Sebeková K
    Diabet Med; 2014 May; 31(5):581-5. PubMed ID: 24111899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac troponin I and beta 2 microglobulin as risk factors for early-onset atherosclerosis in patients on haemodialysis.
    Zumrutdal A; Sezer S; Demircan S; Seydaoglu G; Ozdemir FN; Haberal M
    Nephrology (Carlton); 2005 Oct; 10(5):453-8. PubMed ID: 16221094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced glycation end products (AGEs) and the soluble receptor for AGE (sRAGE) in patients with type 1 diabetes and coeliac disease.
    Bakker SF; Tushuizen ME; Gözütok E; Çiftci A; Gelderman KA; Mulder CJ; Simsek S
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):230-5. PubMed ID: 25467215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced glycation end products in the skin are enhanced in COPD.
    Hoonhorst SJ; Lo Tam Loi AT; Hartman JE; Telenga ED; van den Berge M; Koenderman L; Lammers JW; Boezen HM; Postma DS; Ten Hacken NH
    Metabolism; 2014 Sep; 63(9):1149-56. PubMed ID: 25034386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease.
    Ueno H; Koyama H; Tanaka S; Fukumoto S; Shinohara K; Shoji T; Emoto M; Tahara H; Kakiya R; Tabata T; Miyata T; Nishizawa Y
    Metabolism; 2008 Oct; 57(10):1452-7. PubMed ID: 18803952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased advanced glycation end-products (AGEs) assessed by skin autofluorescence in schizophrenia.
    Kouidrat Y; Amad A; Desailloud R; Diouf M; Fertout E; Scoury D; Lalau JD; Loas G
    J Psychiatr Res; 2013 Aug; 47(8):1044-8. PubMed ID: 23615188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy.
    Chabroux S; Canouï-Poitrine F; Reffet S; Mills-Joncour G; Morelon E; Colin C; Thivolet C
    Diabetes Metab; 2010 Apr; 36(2):152-7. PubMed ID: 20137994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus.
    de Leeuw K; Graaff R; de Vries R; Dullaart RP; Smit AJ; Kallenberg CG; Bijl M
    Rheumatology (Oxford); 2007 Oct; 46(10):1551-6. PubMed ID: 17848401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts.
    Nienhuis HL; de Leeuw K; Bijzet J; Smit A; Schalkwijk CG; Graaff R; Kallenberg CG; Bijl M
    Rheumatology (Oxford); 2008 Oct; 47(10):1554-8. PubMed ID: 18701539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin autofluorescence is elevated in neovascular age-related macular degeneration.
    Mulder DJ; Bieze M; Graaff R; Smit AJ; Hooymans JM
    Br J Ophthalmol; 2010 May; 94(5):622-5. PubMed ID: 19726430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of advanced glycation end products (AGEs) are independently correlated with circulating levels of dipeptidyl peptidase-4 (DPP-4) in humans.
    Tahara N; Yamagishi S; Takeuchi M; Tahara A; Kaifu K; Ueda S; Okuda S; Imaizumi T
    Clin Biochem; 2013 Mar; 46(4-5):300-3. PubMed ID: 23219738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue advanced glycation end product deposition after kidney transplantation.
    Crowley LE; Johnson CP; McIntyre N; Fluck RJ; McIntyre CW; Taal MW; Leung JC
    Nephron Clin Pract; 2013; 124(1-2):54-9. PubMed ID: 24135496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis.
    Gerdemann A; Lemke HD; Nothdurft A; Heidland A; Münch G; Bahner U; Schinzel R
    Clin Nephrol; 2000 Oct; 54(4):276-83. PubMed ID: 11076103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidative stress - a link between endothelial injury, coagulation activation, and atherosclerosis in haemodialysis patients.
    Pawlak K; Naumnik B; Brzósko S; Pawlak D; Myśliwiec M
    Am J Nephrol; 2004; 24(1):154-61. PubMed ID: 14726627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum advanced glycation end products (AGEs) are associated with insulin resistance.
    Tan KC; Shiu SW; Wong Y; Tam X
    Diabetes Metab Res Rev; 2011 Jul; 27(5):488-92. PubMed ID: 21337488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients.
    Okuno S; Ishimura E; Kohno K; Fujino-Katoh Y; Maeno Y; Yamakawa T; Inaba M; Nishizawa Y
    Nephrol Dial Transplant; 2009 Feb; 24(2):571-7. PubMed ID: 18799606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Examination of skin autofluorescence for the determination of glycation end-products in patients on chronic hemodialysis].
    Golubev RV; Papayan GV; Glazunova AA; Korosteleva NY; Petrishchev NN; Smirnov AV
    Ter Arkh; 2016; 88(6):65-72. PubMed ID: 27296264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.